Albireo Pharma Inc.
13F holders, Q4 2024 (December 31)3holders +1
2new positions
1sold out
$0.00avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Albireo Pharma Inc. in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Bessemer Group Inc. ($0), Brooklyn Investment Group ($0) and Tucker Asset Management LLC ($0).
- Company
- Albireo Pharma Inc.
- CUSIP
- 013CVR022
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 30 shares bought and 150,183 shares sold, net −150,153 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Bessemer Group Inc. | 0.00% | New | 20 | $0 |
| Brooklyn Investment Group | 0.00% | New | 10 | $0 |
| Tucker Asset Management LLC | 0.00% | No change | 150 | $0 |
"% of holder's portfolio" is ALBIREO PHARMA INC's weight in each manager's 13F, not the share of Albireo Pharma Inc. the manager owns.